To the best of our knowledge, this is the first study determining that miR-30-5p suppresses NF-κB signaling and MAPK pathway-induced inflammatory responses as well as apoptosis and protects cell survival targeting TCF21 in the in vitro atherosclerosis model (Figure 6). Here, NFKB1 is linked to atherosclerosis.